AG
PRAH

Advisor Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Advisor Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$104K Sell
939
-201
-18% -$20.7K ﹤0.01% 2921
2019
Q3 		$114K Sell
1,140
-156
-12% -$15.5K ﹤0.01% 2794
2019
Q2 		$129K Buy
1,296
+142
+12% +$13.6K ﹤0.01% 2660
2019
Q1 		$128K Sell
1,154
-195
-14% -$20.4K ﹤0.01% 2645
2018
Q4 		$124K Sell
1,349
-5,075
-79% -$513K ﹤0.01% 2468
2018
Q3 		$708K Buy
6,424
+5,323
+483% +$554K 0.01% 1216
2018
Q2 		$103K Sell
1,101
-5,815
-84% -$501K ﹤0.01% 2505
2018
Q1 		$574K Buy
6,916
+1,532
+28% +$136K 0.01% 1222
2017
Q4 		$490K Buy
5,384
+4,315
+404% +$359K 0.01% 1345
2017
Q3 		$81K Buy
1,069
+20
+2% +$1.51K ﹤0.01% 2585
2017
Q2 		$79K Sell
1,049
-10
-0.9% -$693 ﹤0.01% 2503
2017
Q1 		$69K Sell
1,059
-7
-0.7% -$412 ﹤0.01% 2454
2016
Q4 		$59K Buy
1,066
+131
+14% +$7.19K ﹤0.01% 2485
2016
Q3 		$53K Buy
935
+117
+14% +$5.74K ﹤0.01% 2500
2016
Q2 		$32K Buy
+818
New +$37.7K ﹤0.01% 2743

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Advisor Group's PRAH Position: Q4 2019 in Review

Advisor Group reduced its PRA Health Sciences, Inc. (PRAH) stake by 18% in Q4 2019, selling an estimated $20.7K and leaving 939 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2921.

Advisor Group first reported a position in PRAH in Q2 2016 and has held it in 15 quarters since. The position peaked at $708K in Q3 2018. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Advisor Group held 939 shares of PRA Health Sciences, Inc. worth $104K as of Q4 2019.
  • Advisor Group sold 201 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $20.7K.
  • PRA Health Sciences, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2921 holding.
  • Advisor Group first reported a position in PRA Health Sciences, Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's PRA Health Sciences, Inc. position peaked at $708K in Q3 2018.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.